QQ客服 官方微博 反馈留言

	Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
	Cho, Byoung Chul; De Pas, Tommaso; Kalofonos, Haralabos; Wang, Qun; Ramlaus, Rodryg; Cheng, Ying; Vitiello, Fabiana; Laisaar, Tanel; Vallieres, Eric; Kubisa, Bartosz
刊名	ANTICANCER RESEARCH
	2019
卷号	39期号:3
关键词	Non-small cell lung cancer MAGE-A3 cancer immunotherapeutic prognostic factors placebo overall survival
ISSN号	0250-7005
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3599005
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Cho, Byoung Chul,De Pas, Tommaso,Kalofonos, Haralabos,et al. Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study[J]. ANTICANCER RESEARCH,2019,39(3).
APA	Cho, Byoung Chul.,De Pas, Tommaso.,Kalofonos, Haralabos.,Wang, Qun.,Ramlaus, Rodryg.,...&Vansteenkiste, Johan.(2019).Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study.ANTICANCER RESEARCH,39(3).
MLA	Cho, Byoung Chul,et al."Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study".ANTICANCER RESEARCH 39.3(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。